Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 1999

View Archived Issues

Maxamine advances in phase II and III trials during Q2 1999

Aastrom Biosciences enters distribution agreements for Norway and Switzerland

Cell Therapeutics advances oncology portfolio in Q2 1999

CpG ImmunoPharmaceuticals obtains financing for additional clinical trials

Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms

NIH initiates interstitial cystitis trial

Iomed begins phase III trials of IontoDex for inflammation

ACES will evaluate azithromycin in heart disease

GlycoDesign to acquire Vascular Therapeutics

NexMed reports results from multiple-use study of topical alprostadil cream

ImClone Systems initiates phase II C225/cisplatin trial

Nexell launches first product from Cytonex diagnostic line

AdProTech reaches C3d adjuvant licensing agreement with University of Cambridge

Tyrosine kinase inhibitors potentially useful for patient-specific treatment of tumors

Triazepinone compounds from Merck KGaA act as AGE formation inhibitors

Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders

Leading BPH treatment to be copromoted by Abbott and Boehringer Ingelheim

5-HT1A receptor agonist LB-50016, a novel putative anxiolytic and antidepressant

Antiangiogenic drug ZD-4190 excels in preclinical testing at AstraZeneca

Merck's newest alphavbeta3 ligands prevent osteoclast-mediated bone resorption

Centaur researches novel treatments for Alzheimer's disease

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Improved NNRTIs reported by Medivir in patent literature

Cangene receives notification of fast-track status for new anti-chickenpox product

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Sanofi-Synthelabo submits MAA for Ditropan XL in the U.K.

Alusuisse-Lonza announces demerger plans

Argent gene delivery platform used successfully for sustained, controlled delivery of hGH

Remune clinical trial commences in South America

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...